EICHORPublic-registry site landscape for NCT03710291, “Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis”, a Metabolic Acidosis study sponsored by Tricida, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03710291 (registry record) |
| Study title | Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis |
| Official title | A Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects With Metabolic Acidosis |
| Sponsor | Tricida, Inc. |
| Condition(s) | Metabolic Acidosis; Chronic Kidney Disease |
| Phase | PHASE3 |
| Listed sites | 203 |
| Site countries | United States, Albania, Argentina, Armenia, Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia |
Patient-friendly overview of this study: eichor.com/study/NCT03710291.
Eichor generates a preliminary site-risk snapshot for NCT03710291 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Metabolic Acidosis trials
← Eichor home · All tracked trials · Metabolic Acidosis studies · Weekly briefs
